Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-29 @ 6:57 AM
Study NCT ID:
NCT03861403
Status:
TERMINATED
Last Update Posted:
2023-11-30
First Post:
2019-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
Sponsor:
Leap Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-14
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-26
First Submit QC Date:
None
Study First Post Date:
2019-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-27
Last Update Post Date:
2023-11-30
Last Update Post Date Type:
ACTUAL